Skip to content
Screener
USANA Health Sciences logo

USANA Health Sciences

USNA

USANA Health Sciences develops and manufactures science-based nutritional supplements, functional foods, and personal care products.

Market cap
$421.7M-20.5%
Revenue$925.9M+5.7%
Net income$20.1M-52.3%
Free cash flow$31.0M-52.8%
EPS (diluted)$1.06-51.6%
Trailing twelve months · change vs. prior year

Earnings

Next report

Oct 28, 2026 (in 3 months)
Revenue estimate$224.7M
EPS estimate$0.43

Financials

Q1 2026

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation & ratios

Valuation

See full
Market cap$421.7M-20.5%
P/E21×
P/S0.5×-0.1×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp

Returns & leverage

See full
Current ratio2.5×+0.5×

Segments

By geography

See full
Greater China$123.3M+3.9%
Americas and Europe$80.9M+6.2%
Southeast Asia Pacific$30.7M-14.2%
North Asia$15.4M-18.9%

By segment

See full
Core Nutritional$204.4M
Hiya$32.2M-13.3%
Rise$13.7M

Competitors

Profile

USANA Health Sciences develops and manufactures science-based nutritional supplements, functional foods, and personal care products. The company operates through an omni-channel platform including direct selling, direct-to-consumer, and retail channels to promote long-term health and wellness. Its value proposition is centered on high-quality cellular nutrition and a rewarding business opportunity for independent distributors.

Competitive position

A leading global provider of cellular nutrition with a significant vertically integrated manufacturing presence and a dominant market position in Mainland China.

GeographiesChina, United States, Canada, Mexico, Australia, South Korea, India, Europe
Customer segmentsHealth-conscious consumers, Families, Independent distributors, Retailers
Business modelDirect Selling, Subscription, Direct-to-Consumer (DTC), Omni-channel, Manufacturing
SuppliersRaw material ingredient suppliers, Third-party contract manufacturers, IT platform providers
CustomersIndependent Brand Partners, Preferred Customers, Retail consumers, Brick-and-mortar retail partners, Third-party marketplaces
Listed1993
Employees1.9K
CEOKevin G. Guest
FilingsSEC EDGAR

FAQ

What is USANA Health Sciences's market cap?
USANA Health Sciences (USNA) has a market capitalization of $421.7M and trades on NYSE.
What is USANA Health Sciences's revenue and profitability?
USANA Health Sciences generated $925.9M in trailing twelve-month revenue with net income of $20.1M, representing a net margin of 1.9%. Gross margin stands at 77.6%, with free cash flow of $31.0M. These figures are based on the Q2 2026 filing.
Who are USANA Health Sciences's competitors?
USANA Health Sciences's key competitors include Nu Skin, Herbalife, Nature's Sunshine Products Inc., and others. These companies compete in similar markets and product categories.
Who does USANA Health Sciences partner with?
USANA Health Sciences's notable partners include Amazon.
What subsidiaries does USANA Health Sciences have?
USANA Health Sciences's subsidiaries include BabyCare, Hiya Health Products, LLC, Rise, and others.
Where is USANA Health Sciences headquartered?
USANA Health Sciences is headquartered in United States of America and employs approximately 1,900 people. It has been publicly traded since 1993.